GREENWICH, Conn. -- Breakthrough Therapeutics, a privately owned biotechnology company, today announced the publication of positive data with a vaccine for chronic myeloid leukemia CML known as VAX100, in the Journal Lancet. VAX100 is a BCR-ABL peptide vaccine designed to reduce persistent disease in patients with CML whom have had...
BETHESDA, Md.--BUSINESS WIRE--June 6, 1996--Privately held Discovery Communications, Inc. DCI, parent company of cable television's Discovery Channel, today confirmed the closing of its purchase of the assets of The Nature Company from CML Group, Inc. (NYSE: CML) for $40 million.
Apr. 30--Looking to focus on its core exercise and gardening businesses, CML Group Inc. of Acton said yesterday that it has agreed to sell its 117- store The Nature Company chain to Discovery Communications Inc., owner of the Discovery Channel, for $40Apr. 30--Looking to focus on its...
CAMBRIDGE, Mass. -- ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today announced publication, for the first time, of the high-resolution structure of the protein responsible for one of the major clinically relevant genetic variants of drug-resistant chronic myeloid leukemia CML. These findings by a team of ARIAD scientists were used to guide...
The Food and Drug Administration FDA announced in late December the approval of Gleevec (imatinib mesylate; Novartis Pharmaceuticals Corporation) for the first-line treatment of patients with chronic myeloid leukemia CML. Gleevec was first approved inThe Food and Drug Administration FDA announced in late December the approval of Gleevec (imatinib mesylate;...
Tokyo, Japan, Mar 27, 2007 - JCN Newswire - NEC has demonstrated an extended reach 10 Gbps XFP transceiver for 160 km links without dispersion compensation. This transceiver leverages NEC's Planar Lightwave Circuit PLC technologies with AZNA's extended reach Chirp Managed Laser CML technology for a potentially low cost,...
NEC has demonstrated an extended reach 10 Gbps XFP transceiver for 160 km links without dispersion compensation. This transceiver leverages NEC's Planar Lightwave Circuit PLC technologies with AZNA's extended reach Chirp Managed Laser CML technology for a potentially low...
GREENWICH, Conn. -- Breakthrough Therapeutics, a privately owned biotechnology company, today announced the presentation of positive interim data for a novel vaccine known as VAX100 for patients with persistent chronic myeloid leukemia CML while on imatinib mesylate (GleevecR; Novartis). This two-year follow-up data was presented at the annual American Society...
MELBOURNE, March 17 Asia Pulse - Tabulated results for Coles Myer Ltd (ASX:CML), 26 weeks to January 26, 2003. MELBOURNE, March 17 Asia Pulse - Tabulated results for Coles Myer Ltd (ASX:CML), 26 weeks to January 26, 2003.
Continuing to lead the drive for innovation in the high-end telecom market, Finisar Corporation (NASDAQ: FNSR) today announced the completion of Telcordia GR-468 qualification and general availability of its 10 Gbps DM80 and DM200 narrowly tunable CMLTM Butterfly Transmitters for DWDM 300-pin transponders and telecom line card applications. Leveraging...
GlobeImmune, Inc. announced today results from research on its GI-10001 Tarmogen® which is being investigated for the treatment of drug resistant chronic myelogenous leukemia CML. Leukemia driven by the Bcr-Abl T315I mutation, known as the "gate-keeper" mutation, is resistant to treatment with imatinib mesylate or newer tyrosine kinase inhibitors including...
Oct. 1--The CML Group of Acton, perhaps best known for its NordicTrack exercise equipment, yesterday reported sales drops and losses for its fourth quarter and fiscal 1996. Oct. 1--The CML Group of Acton, perhaps best known for its NordicTrack exercise equipment, yesterday reported sales drops and...
Showcasing key technologies that it recently acquired, Finisar Corporation (NASDAQ: FNSR) today announced an interoperability demonstration between its Chirp Managed Laser (CMLTM) and Optical Duobinary ODB technologies, transmitting 10 Gbps traffic over 200 km of single mode fiber. Finisar is the first company to offer its customers these two...
MELBOURNE, Feb 11 Asia Pulse - Coles Myer Ltd (ASX:CML) shares were back on the slippery slide today, falling more than two per cent. MELBOURNE, Feb 11 Asia Pulse - Coles Myer Ltd (ASX:CML) shares were back on the slippery slide today, falling more...
BRISBANE, April 1 Asia Pulse - The top boss at Coles Myer Ltd (ASX:CML) who has drawn up a blueprint to turn around the ailing retail giant within five years, admits it will be "no walk in the park". BRISBANE, April 1 Asia Pulse...
Gleevec’s discovery, development, and launch was a momentous experience that broke records at every stage: scientists delivering dramatic product efficacy never seen before in the history of cancer treatment; Novartis teams pulling together to greatly accelerate clinical trials, and rapid regulatory approvals. It seemed a perfect story. Indeed, to an...
SYDNEY, May 24 Asia Pulse - Coles Myer Ltd (ASX:CML) Australia's biggest retailer, is believed to be close to offering in-store banking facilities. SYDNEY, May 24 Asia Pulse - Coles Myer Ltd (ASX:CML) Australia's biggest retailer, is believed to be close to offering in-store...
SYDNEY, Nov 14 Asia Pulse - Coles Myer Ltd (ASX:CML) shares fell again today as analysts pointed to earnings risks in the grocery sector because of increased competition. SYDNEY, Nov 14 Asia Pulse - Coles Myer Ltd (ASX:CML) shares fell again today as analysts...
MELBOURNE, Oct 3 Asia Pulse - Coles Myer Ltd (ASX:CML) chief executive John Fletcher admits he's still not a retail expert after 12 months in the job but at least he's become a regular supermarket visitor. MELBOURNE, Oct 3 Asia Pulse - Coles Myer Ltd...